Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Canagliflozin in Advanced CKD

NCT05309785 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT05309785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Canagliflozin in Advanced CKD
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 4
Overall status
Completed
Start date
November 24, 2022
Completion date
July 1, 2026
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd stage 4, ckd stage 5, esrd